Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis
Authors
Keywords
Multiple sclerosis, Alemtuzumab, Thyroid, Side effects
Journal
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-26
DOI
10.1007/s40618-019-01105-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alemtuzumab-induced thyroid dysfunction exhibits distinctive clinical and immunological features
- (2018) Nadia Pariani et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Alemtuzumab as Treatment for Multiple Sclerosis
- (2018) Serafeim Katsavos et al. Cold Spring Harbor Perspectives in Medicine
- Antithyroid drug treatment for Graves’ disease: baseline predictive models of relapse after treatment for a patient-tailored management
- (2018) E. Masiello et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Autoimmune Thyroid Disease in Islet Transplant Recipients Discontinuing Immunosuppression Late After Lymphodepletion
- (2018) Alanna Dunn et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years
- (2018) Ilaria Muller et al. THYROID
- Alemtuzumab CARE-MS I 5-year follow-up
- (2017) Eva Havrdova et al. NEUROLOGY
- Alemtuzumab CARE-MS II 5-year follow-up
- (2017) Alasdair J. Coles et al. NEUROLOGY
- Autoimmune Thyroid Diseases in Patients Treated with Alemtuzumab for Multiple Sclerosis: An Example of Selective Anti-TSH-Receptor Immune Response
- (2017) Mario Rotondi et al. Frontiers in Endocrinology
- 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
- (2016) Douglas S. Ross et al. THYROID
- Management of hyperthyroidism due to Graves’ disease: frequently asked questions and answers (if any)
- (2016) L. Bartalena et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Management of Graves Disease
- (2015) Henry B. Burch et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Graves' disease following immune reconstitution or immunomodulatory treatment: should we manage it any differently?
- (2014) Anthony P. Weetman CLINICAL ENDOCRINOLOGY
- The Incidence and Prevalence of Thyroid Dysfunction in Europe: A Meta-Analysis
- (2014) Ane Garmendia Madariaga et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy
- (2014) O. Tuohy et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis
- (2014) Ruth Ann Marrie et al. Multiple Sclerosis Journal
- Incidence rate and clinical features of hyperthyroidism in a long-term iodine sufficient area of Sweden (Gothenburg) 2003-2005
- (2013) Helena Filipsson Nyström et al. CLINICAL ENDOCRINOLOGY
- Alemtuzumab-Related Thyroid Dysfunction in a Phase 2 Trial of Patients With Relapsing-Remitting Multiple Sclerosis
- (2013) Gilbert H. Daniels et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Thyroid Dysfunction as an Unintended Side Effect of Anticancer Drugs
- (2013) Francesco Torino et al. THYROID
- Serum thyrotrophin at baseline predicts the natural course of subclinical hyperthyroidism
- (2012) G. Das et al. CLINICAL ENDOCRINOLOGY
- Secondary autoimmune diseases following alemtuzumab therapy for multiple sclerosis
- (2012) Lisa Costelloe et al. Expert Review of Neurotherapeutics
- Thyrotropin-Blocking Autoantibodies and Thyroid-Stimulating Autoantibodies: Potential Mechanisms Involved in the Pendulum Swinging from Hypothyroidism to Hyperthyroidism or Vice Versa
- (2012) Sandra M. McLachlan et al. THYROID
- A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis
- (2011) E. J. Fox et al. EUROPEAN JOURNAL OF NEUROLOGY
- Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort
- (2011) M. Cossburn et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started